4//SEC Filing
RIGEL PHARMACEUTICALS INC 4
Accession 0001179110-17-006154
$RIGLCIK 0001034842operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:55 PM ET
Size
8.0 KB
Accession
0001179110-17-006154
Insider Transaction Report
Form 4
VANCE DOLLY
SVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-04-19+62,500→ 62,500 totalExercise: $3.59Exp: 2024-02-27→ Common Stock (62,500 underlying) - Award
Employee Stock Option (Right to Buy)
2017-04-19+150,000→ 150,000 totalExercise: $2.74Exp: 2026-01-26→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]On February 27, 2014 the reporting person was granted an option to purchase 125,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. As previously reported on April 4, 2016, the Compensation Committee determined that the performance condition had been achieved with respect to 62,500 shares of common stock. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved with respect to the remaining 62,500 shares of common stock, resulting in full vesting of the option.
- [F2]On January 26, 2016 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001034842
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:55 PM ET
- Size
- 8.0 KB